BioMedicine
Volume 12

Issue 1

Article 5

2021

A study of Apolipoprotein A1(ApoA1) And Interleukin-10(IL-10) In
Diabetes With Foot Ulcers

Follow this and additional works at: https://www.biomedicinej.com/biomedicine
Part of the Medical Sciences Commons

This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Nanda, Rachita; Patel, Suprava; Ghosh, Amritava; KS, Asha; and Mohapatra, Eli (2021) "A study of
Apolipoprotein A1(ApoA1) And Interleukin-10(IL-10) In Diabetes With Foot Ulcers," BioMedicine: Vol. 12 :
Iss. 1 , Article 5.
DOI: 10.37796/2211-8039.1279

This Original Articles is brought to you for free and open access by BioMedicine. It has been accepted for inclusion
in BioMedicine by an authorized editor of BioMedicine.

ORIGINAL ARTICLE

A study of apolipoprotein A1(ApoA1) and
interleukin-10(IL-10) in diabetes with foot ulcers
Rachita Nanda a,*, Suprava Patel a, Amritava Ghosh b, K.S. Asha a, Eli Mohapatra a
a
b

Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, 492099, India
Department of Endocrinology, All India Institute of Medical Sciences (AIIMS), Raipur, Chhattisgarh, 492099, India

Abstract
Background: The high morbidity, mortality and associated economic burden have entailed to identifying early
biomarker of diabetic foot ulcers (DFU). Pro-inﬂammatory and anti-inﬂammatory molecules play a role in the chronic
inﬂammation associated with diabetic foot ulcers (DFU).
Aim: This study aims to ﬁnd the association between ApoA1, IL-10, TNF-a and diabetic foot ulcers, and whether their
levels can assess the severity of the disease.
Method: Two groups, diabetic mellitus without foot ulcers and diabetes with foot ulcers were recruited for the study.
Detailed clinical history was obtained and blood was collected to measure TNF-a, IL-10 and Apo A1. The association
between variables was analysed using Pearson correlation test. ROC analysis was used to identify cut-off values of
ApoA1, IL-10 and TNF-a in diabetes patients with foot ulcers.
Results: The presence of pro-inﬂammatory parameter, TNF-a, was higher and anti-inﬂammatory biomarkers, HDL,
ApoA1 and IL-10 were lower in patients of DFU than those without foot ulcers (p < 0.001). Increasing age, smoking,
retinopathy, eGFR and inﬂammatory biomarkers like low levels of ApoA1 (p < 0.005) and IL-10 (p < 0.001) signiﬁcantly
contributed to the development of diabetic foot ulcers. ROC curve identiﬁed the cut-off for ApoA1 and IL-10 as 89.82mg/dL
and 78.80pg/mL respectively.
Conclusion: In the light of this study, ApoA1 has the potential to predict DFU. The ﬁnding proposes IL-10 (b = ¡0.37,
p < 0.001) could be considered in stratifying DFU as per its severity.
Keywords: ApoA1, Cytokines, Diabetic foot ulcers, eGFR, TNF-a, Wagners

1. Introduction

D

iabetic foot is associated with high morbidity,
mortality, and economic burden [1e4]. The
non-healing nature of these ulcers is due to the
impairment in usual physiological factors of wound
healing which are blocked due to chronic inﬂammation resulting in the derailment of pro-inﬂammatory and anti-inﬂammatory cytokines.
TNF-a, along with associated hyperglycemia, stimulates apoptosis of ﬁbroblasts, keratinocytes, and
endothelial cells and accounts for the catabolic state of
non-healing ulcers [5,6]. The state of hypoxia in DFU
also up-regulates the regular expression of inﬂammatory cytokines like TNF-a [7]. Thus hyperglycemia
and hypoxia have a synergistic effect on the production of pro-inﬂammatory cytokine release [7]. IL-10, an

anti-inﬂammatory cytokine, inhibits antigen presentation by dendritic cells and macrophage activation
and inﬁltration into the site of injury resulting in inhibition of release of pro-inﬂammatory cytokines [8].
Low IL-10 has also been observed in wound margins
of non-healing ulcers [8,9]. Apo A1 has an anti-inﬂammatory role by interfering with T-cell signaling of
monocytes, hampering the production of IL-1b, TNF-a
[10] and blocking the interplay between T cells and
monocytes. ApoA1 inﬂammatory functions of monocyte in peripheral blood mononuclear cells without
affecting cell proliferation. In wound healing, ApoA1
interferes with the polymerization of C9 and incorporation in the membrane, thus inhibiting the formation of membrane attack complex of complement
[11]. Further, it also increases pentraxin3 to promote
efﬁcient tissue repair [12].
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This study aims to ﬁnd the association between
ApoA1, IL-10, TNF-a, and diabetic foot ulcers and
whether their levels can assess the severity of the
disease.

2. Materials and methods
2.1. Study participants
Seventy-seven participants with type 2 diabetes
mellitus (T2DM) and diabetic neuropathy (deﬁned
as Group I)and 75 participants with T2DM and
diabetic neuropathy with foot ulcers (deﬁned as
Group II) were recruited for this hospital-based
observational study by consecutive recruitment.
Patients were recruited from the outpatient clinics
of Departments of Endocrinology and Surgery between January to December 2019. The study followed
the Declaration of Helsinki guidelines. Institutional
ethics committee approval was obtained before
initiating research work, and written informed consent was obtained from all participants.
Diabetic neuropathy was deﬁned as loss of protective sensation on testing with 10-g monoﬁlament
along with any one of the following: impaired vibration sensation on testing with 128 Hz tuning fork,
pinprick sensation, vibration perception threshold, or
ankle reﬂexes. Diabetic foot ulcer (DFU)was deﬁned
as patients of diabetes with ‘ulceration, infection, or
destruction of deep tissues located in the lower limb
below the ankles [13]. The diabetic foot ulcers were
classiﬁed according to Wagner's classiﬁcation [14]
[Supplementary Table 1]. Patients with ulcers on both
feet or with acute inﬂammation, liver disease, cardiac
failure, varicose veins, peripheral artery disease, malignancy, and psychiatric disorders were not included
in the study. All patients were subjected to clinical
evaluation and detailed history was recorded with the
help of a questionnaire. Data on age, sex, anthropometric measurements, duration of diabetes, and other
medical history were obtained. Systolic blood pressure 140 mm Hg and diastolic blood pressure
90 mm Hg, cholesterol 200 mg/dL, and triglycerides 150 mg/dL were deﬁned as hypertension,
hypercholesterolemia, and hypertriglyceridemia,
respectively [15,16]. Estimated glomerular ﬁltration
rate (eGFR) was calculated using Chronic Kidney
Disease Epidemiology Collaboration (CKD-EPI)
equation; eGFR< 60 mL/min/1.73 m2 was deﬁned as
chronic kidney disease (CKD). Blood sample for
plasma was collected under aseptic conditions for
measurement of ApoA1, IL-10, and TNF-a. ApoA1
was determined in Beckman AU680 analyzer by
immunoturbidimetric immunoassay method using
commercially
available
kits
from
Randox
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Laboratories, Ltd (UK). The assay range for ApoA1
was 5.78e234 mg/dL, intra assay and inter-assay coefﬁcient of variation (CV) were 3.08% and 2.04%,
respectively. IL-10 and TNF-a levels were measured
by enzyme-linked immunosorbent assay (ELISA)
method using kits from KRISHGEN Biosystems. The
intra and inter-assay CV for TNF-a were 3.3% and 9%,
respectively, and for IL-10 were 12% and 10%,
respectively. HbA1c was measured using the HPLC
method using the D-10 testing system (Bio-Rad), urea
by urease method, creatinine and uric acid by modiﬁed Jaffe's and uricase method, respectively. The
cholesterol, triglycerides, and HDL were measured by
cholesterol oxidase peroxidase, GPO-PAP, and direct
estimation, respectively. LDL was calculated using
Friedwald's equation.
2.2. Statistical analysis
The results were statistically analyzed using SPSS
20.0 for Windows and Microsoft Excel. The
KolmogoroveSmirnov test was used to evaluate the
normality of variables. Qualitative data were presented as n (%), normally distributed quantitative
data as mean ± standard deviation (SD). Data not
normally distributed were logarithmically transformed. The difference between groups was
compared using an independent sample t-test. Association between variables was analyzed using the
Pearson correlation test by measuring the correlation
coefﬁcient(r). ROC analysis was used to identify cutoff values of Apo A1, IL-10, and TNF-a in patients
with DFU. Multinomial logistic regression analysis
was used to identify which independent variables
could predict the dependent variables. Results were
considered signiﬁcant when the p-value was <0.05.

3. Results
The demographic, clinical, and biochemical characteristics of the two groups are depicted in Table 1.
The mean age of patients (54.85 ± 9.6), percentage of
males (78.7%), and body mass index (BMI) were
higher in Group II than in Group I (p ¼ 0.03, 0.02,
and 0.01 respectively). The mean duration of diabetes
was more in patients with foot ulcers than those
without foot ulcers (p ¼ 0.005) DFU patients had
more individuals (42.7%) with the duration of diabetes more than ten years in comparison to those
without ulcers (27.2%) (p ¼ 0.04). Only seven patients
were on insulin therapy in Group I in comparison to
29 subjects in Group II (p ¼ 0.000). There was a
signiﬁcantly higher number of smokers and individuals with a family history of diabetes in the foot
ulcer group than without ulcers (p ¼ 0.03). Amongst
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Table 1. Demographic, clinical, and biochemical characteristics in the study groups.
Parameters

Group-I (n ¼ 77)

Group-II (n ¼ 75)

P-value

Age (years)
Male/Female
BMI (kg/m2)
Duration of diabetes (years)
Duration of diabetes; >10 years/<10 years
Active smoking
Family history of diabetes
HbA1C (%)
Creatinine (mg/dL)
eGFR (mL/min/1.73m2)
Uric acid (mg/dL)
Cholesterol (mg/dL)
Triglycerides (mg/dL)
HDL (mg/dL)
LDL (mg/dL)
Apo A1 (mg/dL)*
TNF-a (pg/mL)*
IL-10 (pg/mL)*

51.37 ± 10
48 (62.3)/29 (37.4)
22.53 ± 5.05
7.23 ± 5.02
21 (27.2)/56 (72.7)
9 (11.7)
21 (27.2)
8.68 ± 1.86
1.01 ± 0.23
80.99 ± 18.54
5.7 ± 1.37
152.8 ± 44.73
83.24 ± 32.57
44.8 ± 7.61
74.57 ± 47.21
97.0 (24.5)
65 (170.53)
160.3 (133.33)

54.85 ± 9.6
59 (78.7)/16 (21.3)
24.37 ± 4.24
8.78 ± 6.9
32(42.7)/43 (57.3)
19 (25.3)
33 (44)
9.44 ± 1.76
1.23 ± 0.44
65.25 ± 20.36
6.82 ± 2.25
191.52 ± 50.62
136.47 ± 92.9
39.8 ± 5.6
122.3 ± 49.46
76.0 (31.5)
193.0 (142.38)
32.0 (42.93)

0.03
0.02
0.01
0.005
0.04
0.03
0.03
0.01
0.00
0.00
0.00
0.00
0.00
0.002
0.00
<0.0001
0.0001
<0.0001

Values are in mean(SD), n(%), median (interquartile range).

the biochemical parameters, glycated hemoglobin
A1c (HbA1c), creatinine, and uric acid were signiﬁcantly higher in Group-II (9.44 ± 1.76, 1.23 ± 0.44,
6.82 ± 2.25 respectively) than in Group-I (8.68 ± 1.86,
1.01 ± 0.23, 5.70 ± 1.37 respectively). The eGFR in
patients with ulcers was signiﬁcantly lower than
those without ulcers (p ¼ 0.00). The total cholesterol,
triglycerides, and low-density lipoprotein (LDL) were
signiﬁcantly higher in the ulcers group than without
ulcers, with lower HDL in Group-II(p ¼ 0.002).
Comparing the immunological makers in both
groups, subjects in the DFU group showed a lower
ApoA1 and IL-10 but higher TNF-a when compared
to patients with diabetes without foot ulcers (GroupI). According to Wagner's classiﬁcation, there were
2.67% in grade1, 13.3% in grade 2, 38.6% in grade 3,
33.3% in grade 4 and 12% in grade 5.
To identify the association of independent variables in the study population, known risk factors for
diabetic foot ulcers were considered for analysis. A

signiﬁcantly higher number of patients with foot
ulcers had retinopathy (38.7%) and CKD (44%) than
those without ulcers. Patients with diabetes who
were obese (BMI >25 kg/m2), smokers, had CKD
and had a family history of diabetes had a higher
odds ratio. Similarly, total cholesterol >200 mg/dL
(OR ¼ 6.82, 95% CI ¼ 3.25e14.3) and triglycerides
>150 mg/dL (OR ¼ 9.37, 95% CI ¼ 2.06e42.6) was
strongly seen in DFU patients. Although there were
more hypertensives in the T2DM(n ¼ 31) group than
in DFU(n ¼ 20) group, the difference was not statistically signiﬁcant (p ¼ 0.07) [Table 2].
There was a signiﬁcant negative and positive
correlation of ApoA1 with TNF-a(r ¼ 0.186,
p ¼ 0.018) and IL-10 (r ¼ 0.310, p ¼ 0.000), respectively. Similarly, TNF-a and IL-10 (r ¼ 0.224,
p ¼ 0.004) were negatively associated with each
other [Supplementary Table 2].
Multiple logistic regression analysis as observed
by Chi-square and regression coefﬁcients identiﬁed

Table 2. The measure of association of independent variables in the study population.
Independent variable
BMI >25 kg/m
Hypertension
Retinopathy
CKD (eGFR<60 mL/min/1.73m2)
Smoking
Family history of diabetes
Total Cholesterol >150 mg/dL
Triglycerides >200 mg/dL
HDL (<40 mg/dL)
LDL (>100 mg/dL)
2

Group I (n ¼ 77)
25 (32.4)
31 (40.3)
12 (15.6)
6 (7.8)
9 (12)
21 (27)
30 (39)
2 (3)
11 (14)
10 (13)

Group II (n ¼ 75)
47
20
29
33
19
33
61
15
17
15

(62.6)
(26.7)
(8.7)
(44)
(25)
(44)
(81)
(20)
(23)
(20)

Odds Ratio OR (95% CI)

3.4 (1.78e6.81)
0.53 (0.27e1.12)
3.45 (1.57e7.38)
7.85 (3.19e19.34)
2.56 (1.07e6.10)
2.09 (1.06e4.12)
6.82 (3.25e14.3)
9.37 (2.06e42.6)
1.75 (0.76e4.05)
1.67 (0.69e4.00)

Risk Ratio

Chi-square test

RR (95% CI)

Yates

P

1.86 (1.32e2.6)
0.72 (0.48e1.05)
1.70 (1.26e2.29)
2.2 (1.66e2.9)
1.50 (1.09e2.07)
1.42 (1.04e1.94)
2.92 (1.80e4.72)
1.98 (1.53e2.56)
1.2 (0.91e1.84)
1.27 (0.87e1.83)

12.71
2.5
9.13
22.1
3.84
3.94
26.66
9.89
1.26
0.89

<0.0002
0.07
0.001
<0.001
0.03
0.03
0.001
0.0005
0.19
0.25

Abbreviations: BMI-body mass Index, eGFR-estimated glomerular ﬁltration rate, HDL-high density lipoprotein, LDL-low density lipoprotein, ApoA1-apolipoprotein A1, TNF- tumor necrosis factor, IL-interleukin.
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Table 3. Multinomial logistic regression analysis in patients of diabetic foot ulcers.
Variables

Age
Gender
BMI
Smoking
Duration of diabetes
Hypertension
Retinopathy
eGFR
HbA1C
Apo A1 (mg/dL)
TNF-a (pg/mL)
IL-10 (pg/mL)

Likelihood Ratio Tests

Parameter Estimates

Chi-Square

Signiﬁcance

Regression coefﬁcients

Signiﬁcance

4.884
0.273
0.076
5.321
0.014
2.40
6.136
4.390
1.536
7.779
2.197
59.73

0.027
0.601
0.783
0.032
0.906
0.127
0.013
0.024
0.293
0.005
0.138
0.000

3.072
0.381
0.023
3.017
-0.007
1.128
1.814
1.638
0.764
0.047
0.002
0.037

0.034
0.602
0.784
0.035
0.906
0.130
0.020
0.010
0.317
0.012
0.148
<0.0001

increasing age (p ¼ 0.027), smoking (p ¼ 0.032),
retinopathy (p ¼ 0.013), eGFR (p ¼ 0.024), HbA1C
(p ¼ 0.030) and inﬂammatory biomarkers like low
levels of ApoA1 (p ¼ 0.005) and IL- 10 (p ¼ 0.000) to
be signiﬁcantly associated with diabetic foot ulcers
[Table 3]. The other variables, gender, BMI, duration
of diabetes, hypertension, and TNF-a, were not
signiﬁcant in this model for the study population.
Since the probabilities of inﬂammatory biomarkers ApoA1 and IL-10 were signiﬁcant in predicting the presence of DFU, ROC curve analysis

was conducted on these to identify the cut-off point
for DFU development [Fig. 1]. The cut-offs for
ApoA1 and IL-10 were 89.82 mg/dL and 78.80 pg/
mL respectively. The sensitivity, speciﬁcity, PPV,
and NPV of IL-10 were better than ApoA1, as
evident by the overall accuracy of 89.5% for IL-10
compared to 75% for ApoA1 [Table 4].
To illustrate whether Apo A1 and IL-10 could
predict the severity of ulcers according to their
grade, the DFU group was graded to DFU1(grades
0e2) (n ¼ 20) and DFU2(grades 3e5) (n ¼ 55), and

Fig. 1. Receiver operator characteristics (ROC) curve of APO A1 and IL-10 in predicting the development foot ulcers in diabetes.
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Table 4. Accuracy of ApoA1 and IL-10 in diabetic foot ulcers.
ApoA1
IL-10

Cut off

AUC

Sensitivity (%)

Speciﬁcity (%)

NPV (%)

PPV (%)

ACC (%)

89.82
78.8

0.75 (0.676,0.827)
0.93 (0.891,0.970)

70.0
88.8

65.0
82.5

74.0
94.2

76.05
85.5

75.0
89.5

AUC-Area under the curve, NPV-Negative predictive value, PPV-Positive predictive value, ACC- Accuracy.

tests of difference were utilized. There was no difference in Apo A1 (p ¼ 0.540) and IL-10 (p ¼ 0.856)
levels between these two groups [Supplementary
Fig. 1].

4. Discussion
This study evaluated the association between Apo
A1andother inﬂammatory biomarkers like TNF-a
and IL-10anddiabetic foot ulcers. It was demonstrated that T2DM patients with foot ulcers had
lower Apo A1 and IL-10 than T2DMpatients without
foot ulcers. Low Apo A1 and IL-10 had high sensitivity, speciﬁcity, and predictive values in patients
with DFU, with IL-10 being a superior biomarker to
Apo A1 for the development of DFU. However,
none of these showed utility in estimating the disease severity. This could be attributed to fewer patients in the severe grades of ulcer-like grade 4 and 5
and more in grade 3.
It is well known that DFU is a severe complication
of diabetes associated with poor quality of life and
increased ﬁnancial burden on the family and hence
on the community. Therefore, if certain beacons can
serve as early indicators in developing diabetic foot
ulcers, this can beneﬁt the patients. The inﬂammatory state associated with ulcers results in the
release of various non-speciﬁc cytokines of proinﬂammatory and anti-inﬂammatory nature. Multiple
factors play a role in the development of foot ulcers.
In this study, different variables were compared
between DFU patients and patients with diabetes
and without foot ulcers to try and establish the association of Apo A1 with the severity of diabetic
foot. The overall characteristics of the patient population were similar to various other studies in India
as mentioned below and so are generalizable to the
population of the subcontinent.
The mean age of the ulcer group was 54.85 ± 9.6
years, and the prevalence in male gender in our
study is similar to other studies [1,17,18]. Increasing
age and male gender are known independent risk
factors for the development of diabetes, as males
have a higher exposure to trauma, use improper
footwear, and have high foot pressure. Our study
has found age to be a prominent risk factor, whereas
found gender is not to be a risk factor for DFU. Few
studies have found no difference in sex between

diabetic patients with and without foot ulcers
[19,20]. We assume that the degree of neuropathy,
joint mobility, and foot pressure was the same in
males and females, and this could be the reason for
gender not being a risk factor in this population.
Results of Chi-square and Exact measures of association suggested several factors with potential
association with DFU in our study. There was a
signiﬁcant association of obesity (BMI>25 kg/m2) on
the risk of developing DFU (OR-3.4, CI: 1.78e6.81),
similar to other studies [18,21,22]. Smoking, a longer
duration of diabetes (>10 years), and a family history of diabetes mellitus were strongly associated
with foot ulcers. As per many studies, this was
identiﬁed as a risk factor for neuropathy [18,21,23].
Smokers were 2.56 times (CI: 1.07e6.10) more likely
to be associated with diabetic foot ulcers. As the
duration of diabetes increases, macrovascular and
microvascular complications become more common, which further increase the development of
DFU. Retinopathy (OR-3.45, CI: 1.57e7.38) had a
strong association with DFU. Poor glycemic control
was also associated with DFU cases in this study
(p ¼ 0.01). The renal function and lipid proﬁle were
more deranged in Group-II than in Group-I. However, upon multivariable analysis, from amongst the
above factors, our study drew conclusion only of age
(b ¼ 3.072, p ¼ 0.034), smoking (b ¼ 3.017, p ¼ 0.035),
retinopathy (b ¼ 1.814, p ¼ 0.02)and CKD (b ¼ 1.638,
p ¼ 0.01)as independent associated with DFU.
Due to the inﬂammatory status in DFU, there was
a high concentration of pro-inﬂammatory mediator
TNF-a and lower levels of the anti-inﬂammatory
cytokine, IL-10. Lower levels of ApoA1, an anti-inﬂammatory molecule were strongly associated with
DFU. TNF-a is produced by monocytes, macrophages and Tcells affecting many pathways like
adhesion, migration, angiogenesis, and apoptosis. In
normal skin wounds, TNF-a is quickly released by
the vascular endothelium of the ulcer areas, and it
initiates the inﬂammatory process for wound healing [24]. In DFU, which is a chronic non-healing
state, there is prolonged and excessive production of
TNF-a by M1 macrophages (classically activated
macrophages) that promotes a positive ampliﬁcation circuit. This can impair the migration of keratinocytes and ﬁbroblasts to the wound site and
reduce angiogenesis by adversely affecting

endothelial progenitor cells mobilization. The most
conspicuous response is lowering the ability of
macrophages to phagocytose wound debris and
apoptotic neutrophils [25]. The consistent hyperglycemia leads to the accumulation of advanced
glycation end products and induces nuclear factorkB(NF-kB), transcription factors related to cytokines
like TNF-a [26]. The M2 cells (alternatively activated
macrophages) released during wound healing produce IL-10 that attenuate injury and suppress
inﬂammation by releasing vascular endothelial
growth factors [27]. Overall in patients with diabetes, an imbalance towards M1 macrophages increases expression of pro-inﬂammatory cytokines
like TNF-a and decreases IL-10 production
(r ¼ 0.224, p ¼ 0.004) by M2 cells, and delays
wound healing [28]. Studies in diabetic rats have
shown that applying neutralizing TNF-a antibody
and TNF-a antagonists have promoted healing of
the wounds by increasing the migration capacity of
keratinocytes [29]. However, amongst the cytokines
only IL-10 (b ¼ 0.37, p ¼ 0.000) and not TNF-a
(b ¼ 0.002, p ¼ 0.138) could help in predicting DFU.
It can be assumed thatIL-10 has a complementary
action to TNF-a.
ApoA1 has been shown to exert an anti-inﬂammatory effect on macrophages, thus inhibiting
atherogenesis [30]through various mechanisms like
mRNA decay of pro-inﬂammatory cytokines [31].
Experimental studies in mice have shown that injection of ApoA1 leads to an increase in M2 polarisation markers [IL-10] and a decline in
inﬂammatory markers [32]. Therefore, a lower HDL
and ApoA1 level shift the cells away from an M2
macrophage phenotype aggravating the condition
and delaying the healing of the DFU. ApoA1 was
signiﬁcantly lowered in DFU patients and served as
independent markers for DFU occurrence in diabetic patients (b 0.47, p ¼ 0.012). There was a
negative correlation of ApoA1 with TNFa(r ¼ 0.186, p ¼ 0.018) and a positive correlation
with IL-10 (r ¼ 0.310, p ¼ 0.000), which are pro-inﬂammatory and anti-inﬂammatory biomarkers. A
decreased HDL is associated with a diminished inﬂammatory immune response. However, although
there was no difference in HDL level in our study,
the ApoA1 content was lowered in ulcer patients.
This could indicate the endogenous anti-inﬂammatory role of ApoA1. Keeping all these factors into
consideration, Apo A1 can be implicated to be an
evolving biomarker for the early diagnosis of diabetic foot ulcers.
Smoking was found to be independently associated with DFU in our study population. The
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oxidative damage due to smoking induces glycotoxins inducing cell damage to vulnerable neural
tissues [33]. Cigarette smoking also induces insulin
resistance, thereby corroborating the presence of
insulin requirements in these patients.
It is notable that early diagnosis and treatment aid
in reducing the incidence of DFU, which is expected
to reduce other complications like amputation and
mortality. Therefore, we propose ApoA1 and IL-10
as inﬂammatory biomarkers for the early diagnosis
of DFU. Expression of serum ApoA1 and IL-10
showed high AUC in the diagnosis of DFU, with IL10 showing greater accuracy than ApoA1. Even
though these two anti-inﬂammatory markers could
not differentiate between the different grades of
ulcers, this does not dissuade the combined use of
these biomarkers can speculate DFU.
In terms of study limitations, since this is a crosssectional study, the dynamics of this biomarker can
also be well studied with prospective follow-up
studies and taking a larger population in each ulcer
grade. The study of time-dependent changes in
these inﬂammatory markers during treatment
would further reveal more information about the
role of ApoA1 and IL-10 in DFU. This study was also
carried out in a single tertiary care hospital with a
limited representation of the entire Indian population with DFU. However, further studies are
required to completely elucidate its role as a
biomarker, set target serum levels, and increase its
clinical use.

5. Conclusion
Although molecular targets like a pro and antiinﬂammatory cytokines can serve as biomarkers, it
is challenging to pinpoint them for DFU. However,
the present study has demonstrated that Apo A1
and IL-10 are signiﬁcantly reduced in patients with
DFU and are correlated with clinical and laboratory
indices. Although these biomarkers cannot monitor
the severity of DFU, further prospective trials using
cut-off values would aid in the early prediction of
DFU so that timely management of these patients
can be undertaken. Anti-inﬂammatory molecules,
ApoA1 and IL-10, can serve as novel predictors for
the occurrence of DFU and thus reduce the risk of
morbidity and mortality.
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Supplementary Data
Supplementary Table 1. Wagner's classiﬁcation of diabetic ulcer
Ulcer grading

Clinical description

Grade
Grade
Grade
Grade
Grade
Grade

Intact skin (impending ulcer)
Superﬁcial ulcer
Deep ulcer, no bone involvement or abscess
Abscess with bone involvement (osteomyelitis)
Localized gangrene e.g. toes, heel
Extensive gangrene involving entire foot

0
1
2
3
4
5

Supplementary Table 2. Correlation matrix of ApoA1 with TNF-a and
IL-10
Apo A1
TNF-a
IL-10

Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)
Pearson Correlation
Sig. (2-tailed)

Apo A1

TNF-a

IL-10

1

-0.186*
0.018
1

0.310**
0.000
-0.224**
0.004
1

-0.186*
0.018
0.310**
0.000

-0.224**
0.004

*Correlation is signiﬁcant at the 0.05 level (2-tailed). **. Correlation is signiﬁcant at the 0.01 level (2-tailed).
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